Related Experiment Videos
Gene therapy and pancreatic cancer
A S Pearson1, M Bouvet, D B Evans
1Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. apearson@notes.mdacc.tmc.edu
Abstract:
Adenocarcinoma of the pancreas is associated with a short survival due to frequent delays in diagnosis and the lack of effective systemic therapies. Advances in understanding the molecular basis of pancreatic cancer have allowed identification of molecular targets which are amenable to therapeutic intervention. Such targets include p53, K-ras, p16, and DPC-4. Gene therapy involves the transfer of genetic constructs which alter the neoplastic potential of the cancer cell. Vectors used in gene transfer include viral and non-viral methods. Presently, gene therapy of pancreatic cancer is limited to pre-clinical studies using in vitro and in vivo models. However, the initial results from these pre-clinical studies have been encouraging and will form the basis for clinical studies of gene transfer in patients with pancreatic cancer.
Insights
Gene therapy shows promise for treating pancreatic adenocarcinoma by targeting key molecular pathways. Early pre-clinical studies offer encouraging results, paving the way for future clinical trials in patients.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Pancreatic adenocarcinoma has a poor prognosis due to diagnostic delays and limited effective treatments.
- Understanding the molecular underpinnings of pancreatic cancer has identified therapeutic targets like p53, K-ras, p16, and DPC-4.
Purpose of the Study:
- To explore the potential of gene therapy as a novel treatment strategy for pancreatic cancer.
- To review the current pre-clinical advancements in gene therapy for pancreatic adenocarcinoma.
Main Methods:
- Gene therapy utilizes viral or non-viral vectors to deliver genetic material.
- Altering the neoplastic potential of cancer cells is the primary goal of gene transfer.
Main Results:
- Pre-clinical studies in vitro and in vivo models have been conducted.
- Initial findings from these pre-clinical investigations are encouraging.
Conclusions:
- Gene therapy represents a promising therapeutic avenue for pancreatic cancer.
- Encouraging pre-clinical data supports the progression to clinical studies for gene transfer in pancreatic cancer patients.